Detailseite
Die funktionelle Rolle von SnoRNAs in NPM1-Wildtyp und -Mutanten AML
Antragsteller
Fengbiao Zhou, Ph.D.
Fachliche Zuordnung
Hämatologie, Onkologie
Biochemie
Zellbiologie
Biochemie
Zellbiologie
Förderung
Förderung von 2019 bis 2022
Projektkennung
Deutsche Forschungsgemeinschaft (DFG) - Projektnummer 413674146
Erstellungsjahr
2022
Zusammenfassung der Projektergebnisse
In this project, we established the first ribomethylome landscape in human AML and normal hematopoietic cells. We identified a critical role for dynamic snoRNA directed rRNA 2’-O-Me in governing protein translation and cancer stem cell phenotypes. This study not only expands our knowledge about AML pathology, but also sheds light on a new regulatory mechanism of gene expression conferred by rRNA modifications. Lastly and most importantly, we found that SNORD127 could be a new potential therapeutic target in AML. Based on these data, we are developing therapeutic approaches targeting SNORD127 in AML.
Projektbezogene Publikationen (Auswahl)
-
Site-specific methylation of 18S ribosomal RNA by SNORD42A is required for acute myeloid leukemia cell proliferation. Blood, 135(23), 2059-2070.
Pauli, Cornelius; Liu, Yi; Rohde, Christian; Cui, Chunhong; Fijalkowska, Daria; Gerloff, Dennis; Walter, Carolin; Krijgsveld, Jeroen; Dugas, Martin; Edemir, Bayram; Pabst, Caroline; Müller, Lutz P.; Zhou, Fengbiao & Müller-Tidow, Carsten
-
A Dynamic rRNA Ribomethylome Drives Stemness in Acute Myeloid Leukemia. Cancer Discovery, 13(2), 332-347.
Zhou, Fengbiao; Aroua, Nesrine; Liu, Yi; Rohde, Christian; Cheng, Jingdong; Wirth, Anna-Katharina; Fijalkowska, Daria; Göllner, Stefanie; Lotze, Michelle; Yun, Haiyang; Yu, Xiaobing; Pabst, Caroline; Sauer, Tim; Oellerich, Thomas; Serve, Hubert; Röllig, Christoph; Bornhäuser, Martin; Thiede, Christian; Baldus, Claudia ... & Müller-Tidow, Carsten
